Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis

被引：0
作者：
Rob W Flynn
Thomas M MacDonald
Adrian Hapca
Isla S MacKenzie
Stuart Schembri
机构：
[1] Ninewells Hospital and University of Dundee,Medicines Monitoring Unit
[2] East Block,Tayside Respiratory Research Group
[3] Ninewells Hospital,undefined
来源：
Respiratory Research | / 15卷
关键词：
COPD; Inhaled steroids; Diabetes; Pneumonia; Cataract;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Increased Pneumonia Risk Associated with Concomitant Use of Inhaled Corticosteroids and Benzodiazepines: A Pharmacovigilance Analysis
    Ma, Junlong
    Liu, Yaxin
    Sun, Yuanyuan
    Guo, Chengxian
    Yang, Guoping
    LUNG, 2024, 202 (05) : 673 - 681
  • [42] Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD A Post Hoc Analysis From the FLAME Trial
    Mathioudakis, Alexander G.
    Bate, Sebastian
    Sivapalan, Pradeesh
    Jensen, Jens-Ulrik Staehr
    Singh, Dave
    Vestbo, Jurgen
    CHEST, 2024, 166 (05) : 987 - 997
  • [43] Response of exhaled nitric oxide to inhaled corticosteroids in patients with stable COPD: A systematic review and meta-analysis
    Lim, Chor-Shen
    Rani, Fauzi Abdul
    Tan, Lan-Eng
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (01) : 218 - 226
  • [44] Inhaled corticosteroids and risk of influenza in patients with asthma: a meta-analysis of randomized controlled trials
    Chen, Hong
    Xu, Zhibo
    Yang, Jing
    Huang, Lan
    Wang, Ke
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (07) : 1771 - 1782
  • [45] Inhaled Corticosteroids Increase Risk of Nontuberculous Mycobacterial Lung Disease: A Nested Case-Control Study and Meta-analysis
    Shu, Chin-Chung
    Wei, Yu-Feng
    Chen, Kuang-Hung
    Chuang, Shulin
    Wang, Ya-Hui
    Wang, Cheng-Yi
    Wang, Hao-Chien
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (04) : 627 - 636
  • [46] Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
    Donald P. Tashkin
    Marc Miravitlles
    Bartolomé R. Celli
    Norbert Metzdorf
    Achim Mueller
    David M. G. Halpin
    Antonio Anzueto
    Respiratory Research, 19
  • [47] Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
    Tashkin, Donald P.
    Miravitlles, Marc
    Celli, Bartolome R.
    Metzdorf, Norbert
    Mueller, Achim
    Halpin, David M. G.
    Anzueto, Antonio
    RESPIRATORY RESEARCH, 2018, 19
  • [48] Triple inhaled therapy of formoterol/glycopyrrolate/budesonide reduces the use of oral corticosteroids and antibiotics during COPD exacerbations in real-world conditions
    Calderon-Montero, A.
    Diez, J. de Miguel
    Gutierrez, R. de Simon
    Tellez, S. Campos
    Moreno, A. D. Chacon
    Aviles, R. Alonso
    Alonso, N. Gonzalez
    Solis, A. Montero
    Pardo, D. Escribano
    APyC Grp
    MEDICINA DE FAMILIA-SEMERGEN, 2025, 51 (04):
  • [49] Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
    Wang, Cheng-Yi
    Lin, You Shuei
    Wang, Ya-Hui
    Lai, Chih-Cheng
    Wang, Hao-Chien
    Chen, Likwang
    Yu, Chong-Jen
    Perng, Diahn-Warng
    Cheng, Shih-Lung
    Hsu, Jeng-Yuan
    Hsu, Wu-Huei
    Tsai, Ying-Huang
    Hsiue, Tzuen-Ren
    Lin, Meng-Chih
    Lin, Hen-, I
    Chang, Yeun-Chung
    Yang, Ueng-Cheng
    Chen, Chung-Ming
    Lin, Cing-Syong
    Wei, Yu-Feng
    Chong, Inn-Wen
    Chen, Chung-Yu
    AGING-US, 2019, 11 (17): : 6863 - 6871
  • [50] Risk of adverse reactions associated with inhaled corticosteroids for chronic obstructive pulmonary disease: A meta-analysis
    Lu, Chenghe
    Mao, Xinghua
    MEDICINE, 2024, 103 (03) : E36609
12345